A phase I/IIa study of cetuximab combined with fruquintinib in the previously treated RAS/BRAF wild-type metastatic colorectal cancer: Results of the CEFRU study
机构：[1]Tradit Chinese Med Hosp Guangdong Prov, Guangzhou, Peoples R China广东省中医院[2]Guangdong Prov Hosp Chinese Med, Guangzhou, Peoples R China广东省中医院[3]Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China广东省人民医院[4]Guangdong Prov Hosp Tradit Chinese Med, Guangzhou, Peoples R China广东省中医院[5]Guangdong Prov Hosp Chinese Med, Dept Oncol, Guangzhou, Peoples R China大德路总院肿瘤科广东省中医院[6]Guangdong Prov Hosp Chinese Med, Dept Image, Guangzhou, Guangdong, Peoples R China广东省中医院
出处：
ISSN：
基金：
1.Beijing Bethune Charitable Foundation; 2.State Key Laboratory of Dampness
Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese
Medicine (SZ2021ZZ40). 3.Guangdong Provincial Bureau of Traditional Chinese Medicine
(20231115).
第一作者机构：[1]Tradit Chinese Med Hosp Guangdong Prov, Guangzhou, Peoples R China[2]Guangdong Prov Hosp Chinese Med, Guangzhou, Peoples R China[3]Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China[4]Guangdong Prov Hosp Tradit Chinese Med, Guangzhou, Peoples R China[5]Guangdong Prov Hosp Chinese Med, Dept Oncol, Guangzhou, Peoples R China[6]Guangdong Prov Hosp Chinese Med, Dept Image, Guangzhou, Guangdong, Peoples R China
推荐引用方式(GB/T 7714)：
Li Yong,Zhang Haibo,Huang Ling,et al.A phase I/IIa study of cetuximab combined with fruquintinib in the previously treated RAS/BRAF wild-type metastatic colorectal cancer: Results of the CEFRU study[J].JOURNAL OF CLINICAL ONCOLOGY.2023,41(16):
APA：
Li, Yong,Zhang, Haibo,Huang, Ling,Liu, Yi-hong,Chen, Xian...&Ye, Yongsong.(2023).A phase I/IIa study of cetuximab combined with fruquintinib in the previously treated RAS/BRAF wild-type metastatic colorectal cancer: Results of the CEFRU study.JOURNAL OF CLINICAL ONCOLOGY,41,(16)
MLA：
Li, Yong,et al."A phase I/IIa study of cetuximab combined with fruquintinib in the previously treated RAS/BRAF wild-type metastatic colorectal cancer: Results of the CEFRU study".JOURNAL OF CLINICAL ONCOLOGY 41..16(2023)
医学